Sept 30 (Reuters) – The weight-loss drug market is booming, with biotech firms racing to capture a slice of the fast-growing sector dominated by Novo Nordisk and Eli Lilly. Analysts expect the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 30 (Reuters) - Yangzhou Guangling District Taihe Rural Micro-finance Co Ltd: * BOARD REVIEWED…
By Shashwat Chauhan and Tharuniyaa Lakshmi Sept 30 (Reuters) - Wall Street's main indexes gained…
WASHINGTON, Sept 30 (Reuters) - US Transportation Secretary Sean Duffy said Wednesday he does not…
Sept 30 (Reuters) - PATRIZIA SE: * EQS-RPT: PATRIZIA SE: RELEASE ACCORDING TO ARTICLE 111C…
VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM FORMER PREMIER LEAGUE MANAGERS ARSENE WENGER, JOSE MOURINHO AND…
By Maximilian Heath BUENOS AIRES, Sept 30 (Reuters) - Long-awaited rains linked to the El…